Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Subtype identification of surgically curable primary aldosteronism during treatment with mineralocorticoid receptor blockade
Avtorji:ID Pintus, Giovanni (Avtor)
ID Seccia, Teresa Maria (Avtor)
ID Amar, Laurence (Avtor)
ID Azizi, Michel (Avtor)
ID Riester, Anna (Avtor)
ID Reincke, Martin (Avtor)
ID Widimský, Jiří (Avtor)
ID Naruse, Mitsuhide (Avtor)
ID Kocjan, Tomaž (Avtor)
ID Negro, Aurelio (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (553,01 KB)
MD5: 9ABE8FA899B4349A30B810EF2C7EB0F4
 
URL URL - Izvorni URL, za dostop obiščite https://pmc.ncbi.nlm.nih.gov/articles/PMC11095898/pdf/hyp-81-1391.pdf
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Background: Current guidelines and consensus documents recommend withdrawal of mineralocorticoid receptor antagonists (MRAs) before primary aldosteronism (PA) subtyping by adrenal vein sampling (AVS), but this practice can cause severe hypokalemia and uncontrolled high blood pressure. Our aim was to investigate if unilateral PA can be identified by AVS during MRA treatment. Methods: We compared the rate of unilateral PA identification between patients with and without MRA treatment in large data sets of patients submitted to AVS while off renin-angiotensin system blockers and β-blockers. In sensitivity analyses, the between-group differences of lateralization index values after propensity score matching and the rate of unilateral PA identification in subgroups with undetectable (≤2 mUI/L), suppressed (<8.2 mUI/L), and unsuppressed (≥8.2 mUI/L) direct renin concentration levels were also evaluated. Results: Plasma aldosterone concentration, direct renin concentration, and blood pressure values were similar in non-MRA-treated (n=779) and MRA-treated (n=61) patients with PA, but the latter required more antihypertensive agents (P=0.001) and showed a higher rate of adrenal nodules (82% versus 67%; P=0.022) and adrenalectomy (72% versus 54%; P=0.01). However, they exhibited no significant differences in commonly used AVS indices and the area under the receiving operating characteristic curve of lateralization index, both under unstimulated conditions and postcosyntropin. Several sensitivity analyses confirmed these results in propensity score matching adjusted models and in patients with undetectable, or suppressed or unsuppressed renin levels. Conclusions: At doses that controlled blood pressure and potassium levels, MRAs did not preclude the identification of unilateral PA at AVS.
Ključne besede:aldosterone, blood pressure, hyperaldosteronism
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:str. 1391-1399
Številčenje:Vol. 81, iss. 6
PID:20.500.12556/DiRROS-27866 Novo okno
UDK:616.4
ISSN pri članku:0194-911X
DOI:10.1161/HYPERTENSIONAHA.124.22721 Novo okno
COBISS.SI-ID:228506371 Novo okno
Opomba:
Datum objave v DiRROS:26.02.2026
Število ogledov:99
Število prenosov:39
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Hypertension
Skrajšan naslov:Hypertension
Založnik:American Heart Association
ISSN:0194-911X
COBISS.SI-ID:10691335 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:aldosteron, krvni tlak, hiperaldosteronizem


Nazaj